日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Efficacy Remaining at Time of Requested Re-Treatment for Cervical Dystonia: A Potential New Treatment Paradigm with DaxibotulinumtoxinA

达西肉毒素A在颈肌张力障碍患者要求再次治疗时的疗效：一种潜在的新治疗模式

期刊:Toxins
影响因子:4
doi:10.3390/toxins17030133
Ellenbogen, Aaron; Hauser, Robert A; Patel, Atul T; McAllister, Peter; Gross, Todd M; Kazerooni, Rashid; Gallagher, Conor J; Hollander, David A
发表日期：2025
文献求助 收藏

A randomized, double-blind, placebo-controlled trial of DaxibotulinumtoxinA for Injection for the treatment of upper limb spasticity in adults after stroke or traumatic brain injury

一项随机、双盲、安慰剂对照试验，研究注射用达西肉毒素A治疗中风或创伤性脑损伤后成人上肢痉挛的疗效

期刊:Pm&r
影响因子:2.8
doi:10.1002/pmrj.13258
Patel, Atul T; Munin, Michael C; Ayyoub, Ziyad; Francisco, Gerard E; Kazerooni, Rashid; Gross, Todd M
中风
心血管
神经科学
发表日期：2025
文献求助 收藏

Long-Term Safety and Efficacy of Repeat Treatments with DaxibotulinumtoxinA in Cervical Dystonia: Results from the ASPEN-Open-Label Study

达西肉毒素A重复治疗颈肌张力障碍的长期安全性和有效性：来自ASPEN开放标签研究的结果

期刊:Movement Disorders Clinical Practice
影响因子:2.7
doi:10.1002/mdc3.70104
McAllister, Peter; Patel, Atul T; Banach, Marta; Ellenbogen, Aaron; Slawek, Jaroslaw; Paus, Sebastian; Jinnah, Hyder A; Evidente, Virgilio; Gross, Todd M; Kazerooni, Rashid; Gallagher, Conor J; Hollander, David A
发表日期：2025
文献求助 收藏

Efficacy and Safety of DaxibotulinumtoxinA for Injection in Cervical Dystonia: ASPEN-1 Phase 3 Randomized Controlled Trial

达西肉毒素A注射治疗颈肌张力障碍的疗效和安全性：ASPEN-1 III期随机对照试验

期刊:Neurology
影响因子:8.5
doi:10.1212/WNL.0000000000208091
Comella, Cynthia L; Jankovic, Joseph; Hauser, Robert A; Patel, Atul T; Banach, Marta D; Ehler, Edvard; Vitarella, Domenico; Rubio, Roman G; Gross, Todd M
发表日期：2024
文献求助 收藏

SYNCHRONIZE: Real-World Retrospective Safety Analysis of Patients Treated with OnabotulinumtoxinA for More than One Therapeutic Indication

同步：一项针对接受A型肉毒杆菌毒素治疗多种适应症患者的真实世界回顾性安全性分析

期刊:Toxins
影响因子:4
doi:10.3390/toxins16100420
Forde, Grace; Brucker, Benjamin M; Becker Ifantides, Kimberly; Patel, Atul T; Mayadev, Angeli; Brown, Theodore; Ayyoub, Ziyad; Martinez, Kenneth; Singh, Ritu; Nelson, Mariana; Battucci, Simona; Yushmanova, Irina; Ukah, Ahunna; Rhyne, Christopher
发表日期：2024
文献求助 收藏

Improvement in Quality-of-Life-Related Outcomes Following Treatment with IncobotulinumtoxinA in Adults with Limb Spasticity: A Pooled Analysis

使用A型肉毒杆菌毒素治疗成人肢体痉挛后，生活质量相关结局得到改善：一项汇总分析

期刊:Toxins
影响因子:4
doi:10.3390/toxins16010019
Molteni, Franco; Wissel, Jörg; Fheodoroff, Klemens; Munin, Michael C; Patel, Atul T; Althaus, Michael; Comes, Georg; Dekundy, Andrzej; Pulte, Irena; Scheschonka, Astrid; Vacchelli, Matteo; Santamato, Andrea
发表日期：2023
文献求助 收藏

Pooled Safety Analysis of IncobotulinumtoxinA in the Treatment of Neurological Disorders in Adults

肉毒杆菌毒素A治疗成人神经系统疾病的汇总安全性分析

期刊:Toxins
影响因子:4
doi:10.3390/toxins15060353
Jost, Wolfgang H; Kaňovský, Petr; Hast, Michael A; Hanschmann, Angelika; Althaus, Michael; Patel, Atul T
发表日期：2023
文献求助 收藏

Development and Characterization of Pentaerythritol-EudragitRS100 Co-processed Excipients as Solid Dispersion Carriers for Enhanced Aqueous Solubility, In Vitro Dissolution, and Ex Vivo Permeation of Atorvastatin

季戊四醇-EudragitRS100 共加工赋形剂作为固体分散体载体的开发和表征，以增强阿托伐他汀的水溶性、体外溶解和体外渗透性

期刊:ACS Omega
影响因子:3.7
doi:10.1021/acsomega.3c02280
Darshan R Telange, Neha M Bhaktani, Atul T Hemke, Anil M Pethe, Surendra S Agrawal, Nilesh R Rarokar, Shirish P Jain
信号转导
发表日期：2023
文献求助 收藏

AbobotulinumtoxinA Versus OnabotulinumtoxinA in Adults with Upper Limb Spasticity: A Randomized, Double-Blind, Crossover Study Protocol

阿博肉毒素A与奥纳肉毒素A治疗成人上肢痉挛：一项随机、双盲、交叉研究方案

期刊:Advances in Therapy
影响因子:4
doi:10.1007/s12325-021-01896-3
Esquenazi, Alberto; Ayyoub, Ziyad; Verduzco-Gutierrez, Monica; Maisonobe, Pascal; Otto, James; Patel, Atul T
发表日期：2021
文献求助 收藏

Correction: Sustained functional benefits after a single set of injections with abobotulinumtoxinA using a 2-mL injection volume in adults with cervical dystonia: 12-week results from a randomized, double-blind, placebo-controlled phase 3b study

更正：一项随机、双盲、安慰剂对照的3b期研究显示，单次注射2毫升A型肉毒杆菌毒素后，成人颈部肌张力障碍患者可获得持续的功能获益：12周结果

期刊:PLoS One
影响因子:2.6
doi:10.1371/journal.pone.0250475
Patel, Atul T; Lew, Mark F; Dashtipour, Khashayar; Isaacson, Stuart; Hauser, Robert A; Ondo, William; Maisonobe, Pascal; Wietek, Stefan; Rubin, Bruce; Brashear, Allison
发表日期：2021
文献求助 收藏